Welcome to our dedicated page for Anaptysbio SEC filings (Ticker: ANAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AnaptysBio, Inc. filings document the company’s transition to a royalty management business and its Nasdaq-listed common stock under the symbol ANAB. Recent Form 8-K and 8-K/A filings cover the completed separation of First Tracks Biotherapeutics, related separation and transition services agreements, pro forma financial information, and material-event reporting tied to the new corporate structure.
The filing record also includes disclosures on operating and financial results, Regulation FD materials, stock repurchase authorizations, governance matters, and contract litigation involving the Jemperli Collaboration and Exclusive License Agreement. These documents frame AnaptysBio’s capital structure, collaboration rights, royalty-related business focus, and public-company reporting obligations.
ANAB affiliate filed a Form 144 proposing sales of Common Stock. The notice lists multiple proposed dispositions by Dennis Mulroy, including individual sales dated 05/15/2026 through 06/12/2026. The filing shows specific trade dates, share counts, and gross proceeds for each listed sale.
ANAB notice of proposed sale: Morgan Stanley Smith Barney LLC intends to sell 35,000 shares of Common Stock on 06/11/2026 via a stock option exercise for $1,848,750.00 in cash. The filing also lists multiple recent open-market dispositions by Dennis Mulroy between 05/15/2026 and 06/10/2026, including several sales of 10,000–22,987 shares with disclosed gross proceeds per trade.
ANAB affiliate filed a Form 144 disclosing multiple proposed and completed dispositions of Common Stock. The filing lists a 06/10/2026 stock option exercise of 20,000 shares (cash exercise) and a series of sales between 05/15/2026 and 06/09/2026 with individual share quantities and gross proceeds shown. The entries name Dennis Mulroy as the selling party and report per-trade proceeds in dollars alongside each share count.
ANAB: Notice of proposed sale of 20,000 shares of Common Stock via a stock option exercise on 06/09/2026, with cash proceeds indicated to the issuer. The filing lists multiple recent disposals by Dennis Mulroy in May–June 2026, including 21,987 shares on 06/08/2026 and 22,491 shares on 06/05/2026.
ANAB affiliate reported proposed sales of Common Stock by Dennis Mulroy via a Form 144 notice. The filing lists multiple sales dates in May–June 2026 with individual transactions such as 22,491 shares for $1,153,671.22 on 06/05/2026 and several 20,000‑share entries in early June. The notice also shows equity awards/issuances including restricted stock grants and a 13,910 share stock option exercise on 06/08/2026.
ANAB (issuer) notice of proposed sale: the filing lists multiple planned dispositions of Common Stock by Dennis Mulroy via stock option exercises and cash settlements. The excerpt shows repeated sales dated from 05/15/2026 through 06/05/2026, with individual transactions such as 20,000 shares on 06/04/2026.
ANAB affiliate filed a Form 144 proposing the sale of 20,000 shares of common stock via a stock option exercise for cash. The filing identifies Morgan Stanley Smith Barney LLC as the broker and shows the proposed sale date as 06/04/2026.
The filing also lists multiple sales by Dennis Mulroy during May–June 2026, including 15,000 shares on 05/29/2026 and 15,467 shares on 05/21/2026, with several other dated transactions and proceeds reported.
ANAB reported a Form 144 registering 20,000 common shares for sale on 06/03/2026. The filing lists the sale method as Stock Option Exercise for 20,000 shares on 06/03/2026 for cash. The excerpt also records multiple sales by Dennis Mulroy during May–June 2026, including 15,000 shares on 05/29/2026 for $834,903.00 and other transactions totaling many tens of thousands of shares in the preceding weeks.
ANAB affiliate filed a Form 144 proposing the sale of 20,000 shares of Common Stock via a Stock Option Exercise on 06/02/2026. The excerpt lists prior cash sales by Dennis Mulroy between 05/15/2026 and 06/01/2026, including individual sale amounts such as $928,071.04 for 15,467 shares on 05/21/2026.
ANAB affiliate reported a proposed resale of 7,691 shares. The filing states 06/01/2026 as the planned sale date and lists the transaction as a stock option exercise with proceeds in cash. The filing identifies Dennis Mulroy as the selling party and shows multiple recent dispositions in May 2026.